A clinical study of pituitrin versus norepinephrine in the treatment of patients with septic shock

Chinese Critical Care Medicine

Volumn 24, Issue 1, 2012, Pages 33-37

  Han, Xu Dong ^a   Sun, Hua ^b   Huang, Xiao Ying ^b   Zhang, Su Yan ^b   Wang, Ya Dong ^b   Ren, Ke ^b   Li, Feng ^b  

^a Intensive Care Unit   (China)

^b NONE

Author keywords

Catecholamine; Norepinephrine; Oxytocin; Pituitrin; Septic shock; Vasopressin

Indexed keywords

CATECHOLAMINE; DOPAMINE; NORADRENALIN; PITUITRIN;

ADD ON THERAPY; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; HEART RATE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK;

AGED; AGED, 80 AND OVER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; PITUITARY HORMONES, POSTERIOR; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL RATE;

EID: 84863158388     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2012.01.008     Document Type: Article

References (14)

1. Annane D, Aegerter P, Jars-Guincestre MC, et al. Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med, 2003, 168: 165-172. (Pubitemid 36920969)
2. Patel BM, Chittock DR, Russell JA, et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology, 2002, 96: 576-582. (Pubitemid 34193495)
3. Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med, 2007, 35: 33-40. (Pubitemid 46035674)
4. Torgersen C, Dünser MW, Wenzel V, et al. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial. Intensive Care Med, 2010, 36: 57-65.
5. Pesaturo AB, Jennings HR, Voils SA. Terlipressin: vasopressin analog and novel drug for septic shock. Ann Pharmacother, 2006, 40: 2170-2177. (Pubitemid 44954436)
6. Lange M, Morelli A, Ertmer C, et al. Continuous versus bolus infusion of terlipressin in ovine endotoxemia. Shock, 2007, 28: 623-629. (Pubitemid 350287450)
7. Albanèse J, Leone M, Delmas A, et al. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med, 2005, 33: 1897-1902. (Pubitemid 41306507)
8. Luckner G, Dünser MW, Jochberger S, et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med, 2005, 33: 2659-2666. (Pubitemid 41682122)
9. Russell JA, Walley KR. Vasopressin and its immune effects in septic shock. J Innate Immun, 2010, 2: 446-460.
10. Clodi M, Vila G, Geyeregger R, et al. Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men. Am J Physiol Endocrinol Metab, 2008, 295: E686-691.
11. Beishuizen A, Thijs LG. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res, 2003,9:3-24. (Pubitemid 36322480)
12. Russell J A, Walley KR, Gordon AC, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med, 2009, 37: 811-818.
13. Kouatli Y. Is pituitary failure the real therapeutic target in septic shock? Med Hypotheses, 2010, 74: 574-577.